"
High Plasma Concentrations of Sclerostin, an Inhibitor of the Wnt Signaling Pathway, in Young Horses Affected by Osteochondrosis"
written by Didier Serteyn, Luis Mendoza, Charlotte Sandersen, Isabelle Caudron, David Piquemal, Pascale Chavatte-Palmer, Jean-Philippe Lejeune,
published by
Open Journal of Orthopedics,
Vol.4 No.12, 2014
has been cited by the following article(s):
|
[1]
|
Is Sclerostin Glycoprotein a Suitable Biomarker for Equine Osteochondrosis?
Journal of Equine Veterinary Science,
2017
DOI:10.1016/j.jevs.2017.11.003
|
|
|
|
|
[2]
|
Impact of feeding and housing on the development of osteochondrosis in foals—A longitudinal study
Preventive Veterinary Medicine,
2016
DOI:10.1016/j.prevetmed.2016.03.003
|
|
|
|